Teva Pharmaceutical Finance Netherlands III BV

CUSIP: 88167AAP6 Class: Corporate Bond - Foreign US$

Pacer Advisors, Inc.'s Holding History (CIK: 0001616667)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 35,000 Value ($000) $35 Avg Close — Range —
Q3 2025
Shares 28,000 Value ($000) $28 Avg Close — Range —
Q2 2025
Shares 85,000 Value ($000) $85 Avg Close — Range —
Q1 2025
Shares 83,000 Value ($000) $82 Avg Close — Range —
Q4 2024
Shares 166,000 Value ($000) $162 Avg Close — Range —
Q2 2024
Shares 118,000 Value ($000) $114 Avg Close — Range —
Q1 2024
Shares 194,000 Value ($000) $188 Avg Close — Range —
Q4 2023
Shares 194,000 Value ($000) $186 Avg Close — Range —
Q3 2023
Shares 234,000 Value ($000) $216 Avg Close — Range —
Q2 2023
Shares 234,000 Value ($000) $216 Avg Close — Range —